1
|
Elmougy F, Elsharkawy M, Hafez M, Atty SA, Baz H, Ibrahim A, Soliman H, Ekladious S, Abdullatif M, Thabet G, Rady N, Afif A, Tolba A, Zaki Z, Musa N. Genetic profiling of CAH Egyptian children: rapid guide to clinical interpretation of common mutations. J Endocrinol Invest 2021; 44:83-93. [PMID: 32358738 DOI: 10.1007/s40618-020-01271-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Accepted: 04/21/2020] [Indexed: 10/24/2022]
Abstract
OBJECTIVES The prevalence of CAH in Egypt is reported to be ten times more than that of the worldwide prevalence. The study aimed at genetic screening of children diagnosed with 21-alpha hydroxylase deficiency congenital adrenal hyperplasia (21OHD-CAH). In addition, the study offers a rapid and easy guide for clinical reporting of common mutations for endocrinologists. METHODS A cohort of 174 unrelated Egyptian children with 21OHD-CAH were screened for 11 common CYP21A2 gene mutations using a strip hybridization assay, and then, bioinformatics analysis was done to report the pathogenicity of the common mutations for clinical classification. RESULTS The most common mutations were I2 splice and p.Q318X. Deletions/conversions comprised 45.9% of the cohort, whereas 7.4% of the cases were negative for all mutations. The least positively detected point mutations were p.P453S, cluster E6, p.R483P, and p.L307FS, which were detected in fewer than 5% of cases. CONCLUSION Strip hybridization assay is a rapid screening tool for the diagnosis of CAH. The authors hypothesized an easy and rapid scheme for clinical interpretation of the strip results to gain the highest value of the strip in diagnosis.
Collapse
Affiliation(s)
- F Elmougy
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - M Elsharkawy
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt.
| | - M Hafez
- Diabetes, Endocrine and Metabolism Pediatric Unit, Cairo University, Cairo, Egypt
| | - S A Atty
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - H Baz
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - A Ibrahim
- Diabetes, Endocrine and Metabolism Pediatric Unit, Cairo University, Cairo, Egypt
| | - H Soliman
- Diabetes, Endocrine and Metabolism Pediatric Unit, Cairo University, Cairo, Egypt
| | - S Ekladious
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - M Abdullatif
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - G Thabet
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - N Rady
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - A Afif
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - A Tolba
- Clinical and Chemical Pathology Department, Faculty of Medicine, Kasr Al-Aini Hospital, Cairo University, Cairo, 11562, Egypt
| | - Z Zaki
- Clinical and Chemical Pathology Department, Minia University, El Minya, Egypt
| | - N Musa
- Diabetes, Endocrine and Metabolism Pediatric Unit, Cairo University, Cairo, Egypt
| |
Collapse
|